(PLX AI) - Lundbeck raises financial guidance range for the full year 2022.• Outlook FY revenue DKK 17,200-17,700 million, up from DKK 16,700-17,300 million previously• Outlook FY EBIT DKK 2,400-2,700
H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the […]
H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) and Seven & i (OTCMKTS:SVNDY – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Dividends H. Lundbeck A/S pays an annual dividend […]
H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Monday, Zacks.com reports. The firm currently has a $27.00 target price on the stock. Zacks Investment Research‘s price target points to a potential upside of 15.58% from […]
Zacks Investment Research upgraded shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) from a hold rating to a buy rating in a research note released on Monday, Zacks.com reports. The firm currently has $27.00 price objective on the stock. According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research […]